Injective Protocol’s New AINJ ETP Could Ignite Institutional Interest in INJ

The Injective protocol recently announced the launch of its first exchange-traded product (ETP), AINJ, issued by 21Shares. This development represents a crucial step toward integrating blockchain technology with traditional financial markets. The AINJ ETP offers traditional investors access to staking rewards in a transparent and regulated manner. Discover how Injective’s latest ETP roll-out could revolutionize

Source: CoinOtag